Recent 8-K filings for CBRRF

• November 4, 2025, 6:59 PM ET other material materiality 0.60 neutral item 5.03item 5.07item 8.01item 9.01

  Chain Bridge I shareholders approve extension to Nov 2026; 393K shares redeemed for ~$4.72M

  Shareholders approved amendment extending deadline for initial business combination from Nov 15, 2025 to Nov 15, 2026.

• October 3, 2025, 7:59 PM ET other material materiality 0.60 neutral item 1.01item 9.01

  Chain Bridge I extends SPAC deadline to Nov 2026 via monthly trust contributions from Fulton AC

  Fulton AC to contribute $0.01 per non-redeemed public share monthly starting Nov 16, 2025.

• September 9, 2025, 7:59 PM ET M&A materiality 0.75 neutral item 8.01item 9.01

  Chain Bridge I and CommLoan sign LOI for $50M pre-money business combination; expects Nasdaq listing

  Non-binding LOI between SPAC Chain Bridge I (CBRRF) and CommLoan, a commercial real estate lending tech company.

• April 23, 2025, 7:59 PM ET other material materiality 0.75 negative item 4.01item 9.01

  Chain Bridge I terminates auditor Frank Rimerman after $200K error, material weakness

  Audit Committee terminated Frank, Rimerman effective April 4, 2025; engaged RBSM as new auditor.

• April 10, 2025, 7:59 PM ET other material materiality 0.85 negative item 1.02item 4.01item 9.01

  Chain Bridge I terminates Phytanix Bio merger agreement; appoints RBSM as new auditor

  Mutual termination of Business Combination Agreement with Phytanix Bio effective April 7, 2025.

• January 29, 2025, 6:59 PM ET other material materiality 0.70 negative item 4.02

  Chain Bridge I restates Q3 2024 financials due to $200K liability understatement, cites material weakness

  Audit Committee determined unaudited Q3 2024 interim financial statements cannot be relied upon due to error.

• November 19, 2024, 6:59 PM ET other material materiality 0.75 negative item 3.01item 5.03item 5.07item 8.01item 9.01

  Chain Bridge I delisted from Nasdaq; shareholders approve extension, 550K shares redeemed

  Nasdaq will suspend trading of CBRG shares and units on Nov 19; shares to trade on OTCQB under symbol CBRRF.

• November 13, 2024, 6:59 PM ET regulatory materiality 1.00 negative item 1.01item 3.01item 8.01item 9.01

  Chain Bridge I receives Nasdaq delisting notice for failing to complete business combination by Nov 4, 2024

  Nasdaq delisting notice received Nov 12; trading suspension effective at open on Nov 19, 2024.

• November 12, 2024, 6:59 PM ET regulatory materiality 0.80 negative item 1.01item 8.01item 9.01

  Nasdaq to delist Chain Bridge I; company signs non-redemption agreements to retain trust funds

  Nasdaq notified Chain Bridge I on Nov 11 it will deliver delisting letter on Nov 12 because it missed the 36-month deadline to complete a business combination.

• July 23, 2024, 7:59 PM ET M&A materiality 0.85 neutral item 1.01item 2.03item 7.01item 9.01

  Chain Bridge I to merge with Phytanix Bio at $58M equity value, ticker to become PHYX

  Business Combination Agreement signed July 22, 2024; closing expected Q4 2024.

• July 1, 2024, 7:59 PM ET debt materiality 0.60 neutral item 1.01item 2.03item 9.01

  Chain Bridge I receives $1.59M bridge loan from Phytanix Bio for working capital and business combination costs

  Phytanix Bio agreed to loan Chain Bridge I $1,590,995.12 on June 26, 2024 via unsecured non-interest bearing promissory note.

• June 26, 2024, 7:59 PM ET regulatory materiality 0.65 negative item 3.01

  Chain Bridge I receives Nasdaq deficiency notice for failing 300 public holders minimum

  Notice on June 20, 2024 for non-compliance with Nasdaq Listing Rule 5550(a)(3) requiring minimum 300 public holders.

Executive changes

Materiality & sentiment trend

Max materiality 1.00 · Median 0.60 · Most common event other_material

1 positive 8 negative 11 neutral

source · CBRRF on sec.gov